SAN DIEGO, June 19, 2017 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that it garnered extensive media coverage from the 4th Annual Cannabis World Congress and Business Expo in New York, which took place on June 14-16.
Medical Marijuana, Inc.'s CEO Dr. Stuart Titus spoke to several television and radio stations about the therapeutic properties of cannabis, recent breakthroughs in medical cannabis research, and the Company's groundbreaking Real Scientific Hemp Oil™ (RSHO™) and zero-THC Real Scientific Hemp Oil-X™ (RSHO-X™).
"We are grateful to the press and to the International Cannabis Association for serving as an effective platform to raise awareness on the plethora of benefits of cannabidiol (CBD)," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "The CWCBE in New York was a huge success. Through the media's coverage of the event, viewers and readers worldwide gain a much better understanding of the power of hemp oil and cannabis products, as well as the businesses that are shaping and supporting this rapidly growing industry."
Coverage from the Expo included:
About Medical Marijuana, Inc.
We are a company of firsts ®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
FORWARD-LOOKING DISCLAIMER AND DISCLOSURES.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties. The statements in this press release have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.
SOURCE Medical Marijuana, Inc.